Ocean Biomedical dismisses Deloitte & Touche as independent auditor effective Dec. 2, 2024

Ocean Biomedical, Inc.

Dismissed Deloitte & Touche LLP as independent registered public accounting firm effective December 2, 2024.
No disagreements with Deloitte on accounting principles, financial statement disclosure, or audit scope during fiscal 2022–2023 or interim period through Dec. 2, 2024.
Deloitte's prior reports contained a going concern explanatory paragraph citing working capital deficiency and anticipated losses.
Board approved the change by written consent on December 2, 2024.
Company requested Deloitte to furnish a letter to the SEC agreeing with the statements; letter attached as Exhibit 16.1.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.